Management of Dry Eye Toxicity After Treatment With 177Lu-PSMA-617 Radioligand Therapy

被引：1
作者：
Pepin, Abigail [1 ]
Lee, Vivian [2 ]
O'Brien, Sophia [3 ]
Mulugeta, Philipose [3 ]
Taunk, Neil K. [1 ]
机构：
[1] Hosp Univ Penn, Dept Radiat Oncol, Philadelphia, PA 19104 USA
[2] Hosp Univ Penn, Dept Ophthalmol, Philadelphia, PA USA
[3] Hosp Univ Penn, Div Nucl Med, Philadelphia, PA USA
来源：
PRACTICAL RADIATION ONCOLOGY | 2024年 / 14卷 / 04期
关键词：
SALIVARY; GLANDS;
D O I：
10.1016/j.prro.2024.04.001
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Treatment options for patients with metastatic castration-resistant prostate cancer include use of radioligand therapy with 177LuPSMA-617. 177Lu-PSMA-617 is used to target prostate cancer cells selectively by targeting prostate specific membrane antigen (PSMA); however, PSMA is also expressed on lacrimal glands among other tissues. Herein, we report on a case of a Common Terminology Criteria for Adverse Events version 5 grade 3 dry eye event with concomitant blepharitis after administration of 177Lu-PSMA-617. The patient was managed with neomycin-polymyxin-dexamethasone 3.5-10000-0.1 ophthalmic suspension, artificial tears, lubricating ointments, lid scrubs, and oral antihistamines. (c) 2024 American Society for Radiation Oncology. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码：301 / 304
页数：4
相关论文
共 15 条
  • [1] Salivary glands regenerate after radiation injury through SOX2-mediated secretory cell replacement
    Emmerson, Elaine
    May, Alison J.
    Berthoin, Lionel
    Cruz-Pacheco, Noel
    Nathan, Sara
    Mattingly, Aaron J.
    Chang, Jolie L.
    Ryan, William R.
    Tward, Aaron D.
    Knox, Sarah M.
    [J]. EMBO MOLECULAR MEDICINE, 2018, 10 (03)
  • [2] THE RELATIONSHIP BETWEEN APOPTOSIS AND ATROPHY IN THE IRRADIATED LACRIMAL GLAND
    GAZDA, MJ
    SCHULTHEISS, TE
    STEPHENS, LC
    ANG, KK
    PETERS, LJ
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1992, 24 (04): : 693 - 697
  • [3] Salivary Gland Side Effects Commonly Develop Several Weeks After Initial Radioactive Iodine Ablation
    Grewal, Ravinder K.
    Larson, Steven M.
    Pentlow, Christina E.
    Pentlow, Keith S.
    Gonen, Mithat
    Qualey, Rebecca
    Natbony, Lauren
    Tuttle, R. Michael
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2009, 50 (10) : 1605 - 1610
  • [4] Developing a Patient-Reported Outcome Measure for Radionuclide Therapy for Prostate Cancer
    Gudenkauf, Lisa M.
    Chavez, Melody N.
    Maconi, Melinda Leigh
    Geiss, Carley
    Seyedroudbari, Ameen
    Thin, Pan
    Hoogland, Aasha I.
    Nguyen, Kathleen
    Murthy, Vishnu
    Armstrong, Wesley R.
    Komrokji, Khaled
    Oswald, Laura B.
    Jim, Heather S. L.
    El-Haddad, Ghassan
    Fendler, Wolfgang P.
    Herrmann, Ken
    Cella, David
    Czernin, Johannes
    Hofman, Michael S.
    Dicker, Adam P.
    Calais, Jeremie
    Tagawa, Scott T.
    Gonzalez, Brian D.
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2023, 64 (06) : 869 - 872
  • [5] Dosimetry of 177Lu-PSMA-617 for the treatment of metastatic castration-resistant prostate cancer: results from the VISION trial sub-study.
    Herrmann, Ken
    Rahbar, Kambiz
    Eiber, Matthias
    Krause, Bernd J.
    Lassmann, Michael
    Jentzen, Walter
    Blumenstein, Lars
    Klein, Patrick
    Basque, Jean-Rene
    Kurth, Jens
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [6] Biomarker response to high-specific-activity I-131 meta-iodobenzylguanidine in pheochromocytoma/paraganglioma
    Jimenez, Camilo
    Chin, Bennett B.
    Noto, Richard B.
    Dillon, Joseph S.
    Solnes, Lilja
    Stambler, Nancy
    DiPippo, Vincent A.
    Pryma, Daniel A.
    [J]. ENDOCRINE-RELATED CANCER, 2023, 30 (02)
  • [7] Radiation dose constraints for organs at risk in neuro-oncology; the European Particle Therapy Network consensus
    Lambrecht, Maarten
    Eekers, Danielle B. P.
    Alapetite, Claire
    Burnet, Neil G.
    Calugaru, Valentin
    Coremans, Ida E. M.
    Fossati, Piero
    Hoyer, Morten
    Langendijk, Johannes A.
    Romero, Alejandra Mendez
    Paulsen, Frank
    Perpar, Ana
    Renard, Laurette
    de Ruysscher, Dirk
    Timmermann, Beate
    Vitek, Pavel
    Weber, Damien C.
    van der Weide, Hiske L.
    Whitfield, Gillian A.
    Wiggenraad, Ruud
    Roelofs, Erik
    Nystrom, Petra Witt
    Troost, Esther G. C.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2018, 128 (01) : 26 - 36
  • [8] Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer
    Parker, C.
    Nilsson, S.
    Heinrich, D.
    Helle, S. I.
    O'Sullivan, J. M.
    Fossa, S. D.
    Chodacki, A.
    Wiechno, P.
    Logue, J.
    Seke, M.
    Widmark, A.
    Johannessen, D. C.
    Hoskin, P.
    Bottomley, D.
    James, N. D.
    Solberg, A.
    Syndikus, I.
    Kliment, J.
    Wedel, S.
    Boehmer, S.
    Dall'Oglio, M.
    Franzen, L.
    Coleman, R.
    Vogelzang, N. J.
    O'Bryan-Tear, C. G.
    Staudacher, K.
    Garcia-Vargas, J.
    Shan, M.
    Bruland, O. S.
    Sartor, O.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (03) : 213 - 223
  • [9] Parsons J T, 1996, Oncology (Williston Park), V10, P837
  • [10] SEVERE DRY-EYE SYNDROME FOLLOWING EXTERNAL-BEAM IRRADIATION
    PARSONS, JT
    BOVA, FJ
    FITZGERALD, CR
    MENDENHALL, WM
    MILLION, RR
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1994, 30 (04): : 775 - 780
12